Munich Reinsurance Co Stock Corp in Munich Sells 4,976 Shares of Lam Research Corporation $LRCX

Munich Reinsurance Co Stock Corp in Munich trimmed its position in Lam Research Corporation (NASDAQ:LRCXFree Report) by 10.6% in the 2nd quarter, Holdings Channel reports. The firm owned 42,175 shares of the semiconductor company’s stock after selling 4,976 shares during the quarter. Munich Reinsurance Co Stock Corp in Munich’s holdings in Lam Research were worth $18,276,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in LRCX. Blalock Williams LLC bought a new stake in Lam Research during the second quarter valued at $436,000. Elevation Wealth Management LLC increased its stake in Lam Research by 4.9% in the 2nd quarter. Elevation Wealth Management LLC now owns 1,858 shares of the semiconductor company’s stock worth $805,000 after acquiring an additional 87 shares during the last quarter. Valued Retirements Inc. purchased a new stake in shares of Lam Research in the 2nd quarter valued at about $204,000. Copley Financial Group Inc. purchased a new stake in shares of Lam Research in the 2nd quarter valued at about $330,000. Finally, LifePlan Investment Advisors Inc. bought a new stake in shares of Lam Research during the 2nd quarter valued at about $393,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
  • Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
  • Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
  • Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
  • Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
  • Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
  • Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Insider Transactions at Lam Research

In other Lam Research news, insider Ava Harter sold 5,000 shares of the firm’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the sale, the insider directly owned 42,462 shares in the company, valued at approximately $12,843,056.52. This trade represents a 10.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Talwalkar sold 18,282 shares of the firm’s stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. This trade represents a 17.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 77,782 shares of company stock valued at $26,755,370 in the last quarter. 0.31% of the stock is owned by insiders.

Lam Research Price Performance

LRCX opened at $307.65 on Friday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. Lam Research Corporation has a 52-week low of $100.68 and a 52-week high of $438.50. The stock has a market capitalization of $384.97 billion, a PE ratio of 53.41, a price-to-earnings-growth ratio of 1.16 and a beta of 1.85. The stock’s 50 day moving average price is $321.34 and its 200-day moving average price is $291.39.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. Lam Research’s quarterly revenue was up 30.0% compared to the same quarter last year. During the same period last year, the business posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, equities research analysts predict that Lam Research Corporation will post 9.33 EPS for the current year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd will be given a $0.33 dividend. The ex-dividend date of this dividend is Wednesday, September 23rd. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. This is a boost from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s payout ratio is presently 18.06%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on LRCX shares. Bank of America upped their price objective on shares of Lam Research from $330.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. Citigroup reaffirmed a “buy” rating and set a $450.00 price target (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. Morgan Stanley cut their price objective on shares of Lam Research from $404.00 to $367.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. Wells Fargo & Company reiterated an “overweight” rating and issued a $350.00 target price (down from $450.00) on shares of Lam Research in a research report on Thursday, July 30th. Finally, Barclays restated an “overweight” rating and set a $335.00 price target (up from $275.00) on shares of Lam Research in a research report on Thursday, June 11th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $358.97.

Check Out Our Latest Stock Analysis on LRCX

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.